KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) Return on Capital Employed (2016 - 2026)

Opko Health filings provide 15 years of Return on Capital Employed readings, the most recent being 1.98% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 1234.0% to 1.98% in Q1 2026 year-over-year; TTM through Mar 2026 was 1.98%, a 1234.0% increase, with the full-year FY2025 number at 2.64%, up 538.0% from a year prior.
  • Return on Capital Employed hit 1.98% in Q1 2026 for Opko Health, up from 2.79% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 1.98% in Q1 2026 to a low of 15.17% in Q2 2024.
  • Median Return on Capital Employed over the past 5 years was 9.04% (2023), compared with a mean of 9.24%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -1767bps in 2022 and later skyrocketed 1234bps in 2026.
  • Opko Health's Return on Capital Employed stood at 11.41% in 2022, then rose by 25bps to 8.56% in 2023, then tumbled by -65bps to 14.13% in 2024, then skyrocketed by 80bps to 2.79% in 2025, then increased by 29bps to 1.98% in 2026.
  • The last three reported values for Return on Capital Employed were 1.98% (Q1 2026), 2.79% (Q4 2025), and 8.06% (Q3 2025) per Business Quant data.